Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
Novo Nordisk ADR (NYSE: NVO) closed the day trading at $78.11 down -1.06% from the previous closing price of $78.95. In other words, the price has decreased by -$1.06 from its previous closing price. On the day, 7.42 million shares were traded.
Ratios:
For a better understanding of NVO, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 71.93 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 24.55. For the most recent quarter (mrq), Quick Ratio is recorded 0.55 and its Current Ratio is at 0.74. In the meantime, Its Debt-to-Equity ratio is 0.72 whereas as Long-Term Debt/Eq ratio is at 0.62.
Valuation Measures:
As of this moment, Novo’s Price-to-Earnings (P/E) ratio for their current fiscal year is 23.80, and their Forward P/E ratio for the next fiscal year is 16.28. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.22. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.24 while its Price-to-Book (P/B) ratio in mrq is 17.41.
Stock Price History:
Over the past 52 weeks, NVO has reached a high of $148.15, while it has fallen to a 52-week low of $77.82. The 50-Day Moving Average of the stock is -8.09%, while the 200-Day Moving Average is calculated to be -32.07%.
Shares Statistics:
A total of 3.37B shares are outstanding, with a floating share count of 3.36B. Insiders hold about 0.01% of the company’s shares, while institutions hold 10.12% stake in the company.
